With 7.13 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.73 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $128.76 whereas the lowest price it dropped to was $127.68. The 52-week range on ABT shows that it touched its highest point at $129.85 and its lowest point at $99.71 during that stretch. It currently has a 1-year price target of $135.41. With its current market cap of 221.89 billion, ABT has annualized dividend of $2.24 while the current yield stands at 1.75%. ABT paid its most recent dividend on 1736899200, while the ex-dividend date for that was 1736899200. Beta for the stock currently stands at 0.75.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ABT was up-trending over the past week, with a rise of 2.32%, but this was up by 13.41% over a month. Three-month performance surged to 12.81% while six-month performance rose 20.76%. The stock gained 12.73% in the past year, while it has gained 13.10% so far this year. A look at the trailing 12-month EPS for ABT yields 7.66 with Next year EPS estimates of 5.70. For the next quarter, that number is 1.07. This implies an EPS growth rate of 10.40% for this year and 10.61% for next year. EPS is expected to grow by 10.51% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 30.08%.
Float and Shares Shorts:
At present, 1.73 billion ABT shares are outstanding with a float of 1.72 billion shares on hand for trading. On 2024-12-31, short shares totaled 14.32 million, which was 83.0 higher than short shares on 1732838400. In addition to Mr. Robert B. Ford as the firm’s Chairman of the Board, President & CEO, Mr. Philip P. Boudreau serves as its CFO & Executive VP of Finance.
Institutional Ownership:
Through their ownership of 0.77552 of ABT’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, ABT reported revenue of $10635000000.0 and operating income of $1859000000.0. The EBITDA in the recently reported quarter was $2872000000.0 and diluted EPS was $0.94.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ABT since 13 analysts follow the stock currently. There are 12 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ABT analysts setting a high price target of 158.0 and a low target of 109.0, the average target price over the next 12 months is 133.07957. Based on these targets, ABT could surge 23.51% to reach the target high and fall by -14.8% to reach the target low. Reaching the average price target will result in a growth of 4.03% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $4.6847 being high and $4.66468 being low. For ABT, this leads to a yearly average estimate of $4.67469. Based on analyst estimates, the high estimate for the next quarter is $1.28 and the low estimate is $1.14. The average estimate for the next quarter is thus $1.24.
#####
#####
#####
#####
